Searched for
TRASTUZUMAB EMTANSINE
Cadila Healthcare Q1 results: Net profit rises 29% to Rs 587 crConsolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the s...- Zydus Cadila launches breast cancer treatment drug Ujvira"In a step that can significantly reduce treatment cost by almost 80 per cent, the drug is being offered at Rs 32,495 for a 100 mg vial. Th...
- Government panel moots clinical trial waiver for two cancer drugsThe two medicines - Aflibercept and Trastuzumab emtansine - are used in treatment of metastatic colorectal cancer and metastatic breast can...
- Load More